Hypothesis

Age‑dependent osteocyte extracellular vesicles enriched in miR‑34a travel to the hippocampus and bind Gpr158 mRNA, suppressing its translation and weakening uOCN‑evoked IP3/BDNF cascades.

Mechanistic Rationale

It's known that uOCN activates Gpr158 in CA3 neurons to raise IP3 and BDNF, rescuing memory deficits[1]. Osteocyte‑derived vesicles carry senescence miRNAs, notably miR‑34a, that amplify synaptic and osteogenic deficits[2]. miR‑34a targets the 3′‑UTR of Gpr158 in other tissues, reducing receptor density and blunting G‑protein signaling. If bone‑derived miR‑34a silences hippocampal Gpr158, the endocrine loop frays: less uOCN signaling → lower BDNF → impaired synaptic plasticity → cognitive decline, while brain leptin resistance further curtails osteoblast activity, creating a vicious cycle.

Testable Predictions

• Osteocyte‑specific overexpression of miR‑34a will reduce hippocampal Gpr158 protein, lower uOCN‑stimulated IP3 accumulation, and produce memory deficits in young mice.
• Inhibiting miR‑34a in osteocytes (using antagomir or conditional Dicer knockout) will preserve Gpr158 levels, sustain uOCN‑BDNF signaling, and protect against age‑related cognitive decline.
• Peripheral injection of purified osteocyte vesicles containing miR‑34a will recapitulate the suppressive effect on hippocampal Gpr158, an effect blocked by vesicle‑release inhibitors (e.g., GW4869).
• Humans with high circulating miR‑34a‑positive osteocyte vesicles will show lower Gpr158 expression in post‑mortem hippocampal tissue and correlate with poorer cognitive scores[4].

Experimental Approach

1. Generate Osx‑CreERT2;miR‑34a floxed mice to inducibly overexpress miR‑34a in osteoblasts/osteocytes; assess vesicle miR‑34a load by qPCR, hippocampal Gpr158 by western blot, IP3 response to uOCN ex vivo, and memory via Morris water maze.
2. Cross Osx‑CreERT2 with Dicer floxed mice to block vesicle miRNA cargo; treat aged mice with antagomir‑34a delivered intracerebroventricularly or systemically; measure cognitive performance and bone parameters.
3. Isolate extracellular vesicles from osteocyte cultures of young vs aged mice, label with fluorescent dye, track hippocampal uptake in vivo, and quantify miR‑34a transfer using FISH.
4. In human cohorts, isolate osteocyte‑derived vesicles from serum, quantify miR‑34a by digital PCR, and relate to CSF BDNF levels and cognitive mini‑mental state exam scores, using data from the oldest‑old female study[4].

If miR‑34a mediated suppression of Gpr158 is confirmed, it would explain why osteoblast‑specific OCN loss yields milder phenotypes than germline deletion (developmental loss of vesicular miR‑34a signaling) and provide a node where bone‑brain crosstalk can be therapeutically uncoupled.